< Home < Back

Sudeep Pharma - Quaterly Results

Date: 05-08-2026
The sales surged to Rs. 1056.83 millions, up 31.82% for the June 2026 quarter as against Rs. 801.74 millions during the corresponding quarter previous year.Good  Net Profit growth of 34.22% reported above the corresponding previous quarter figure of Rs. 252.05 millions to Rs. 338.30 millioins.Operating profit surged to 489.95 millions from the corresponding previous quarter of 370.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1056.83 801.74 31.82 1056.83 801.74 31.82 3385.05 3567.32 -5.11
Other Income 98.00 66.20 48.04 98.00 66.20 48.04 385.04 83.76 359.69
PBIDT 489.95 370.12 32.38 489.95 370.12 32.38 1582.72 1403.33 12.78
Interest 17.60 14.37 22.48 17.60 14.37 22.48 60.66 48.10 26.11
PBDT 472.35 355.75 32.78 472.35 355.75 32.78 1522.06 1355.23 12.31
Depreciation 18.26 17.48 4.46 18.26 17.48 4.46 71.10 61.17 16.23
PBT 454.09 338.27 34.24 454.09 338.27 34.24 1450.96 1294.06 12.12
TAX 115.79 86.22 34.30 115.79 86.22 34.30 375.16 336.59 11.46
Deferred Tax 17.23 4.25 305.41 17.23 4.25 305.41 31.93 5.26 507.03
PAT 338.30 252.05 34.22 338.30 252.05 34.22 1075.80 957.47 12.36
Equity 112.95 97.23 16.17 112.95 97.23 16.17 112.95 97.23 16.17
PBIDTM(%) 46.36 46.16 0.42 46.36 46.16 0.42 46.76 39.34 18.86